吡格列酮可改善接受或未接受降脂治疗的2型糖尿病患者的糖尿病血脂异常。 - Suppr

Suppr

超能文献

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy.

作者信息

Schöfl Christof, Luebben Georg

机构信息

Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany.

出版信息

Clin Drug Investig. 2005;25(5):341-5. doi: 10.2165/00044011-200525050-00007.

DOI:10.2165/00044011-200525050-00007

PMID:17532672

Abstract

摘要

相似文献

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy.

Clin Drug Investig. 2005;25(5):341-5. doi: 10.2165/00044011-200525050-00007.

Therapies for diabetic dyslipidaemia.

Diabetes Obes Metab. 2011 Apr;13(4):313-25. doi: 10.1111/j.1463-1326.2010.01342.x.

Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Drugs. 2007;67(1):121-53. doi: 10.2165/00003495-200767010-00013.

Diabetic dyslipidaemia: insights for optimizing patient management.

Curr Med Res Opin. 2005;21 Suppl 1:S29-40. doi: 10.1185/030079905X36468.

The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.

Diabetologia. 2006 Mar;49(3):527-37. doi: 10.1007/s00125-005-0092-4. Epub 2006 Jan 21.

Pioglitazone plus glimepiride: a promising alternative in metabolic control.

Int J Clin Pract Suppl. 2007 Jun(153):28-36. doi: 10.1111/j.1742-1241.2007.01362.x.

Dyslipidaemia among diabetic patients with ischemic stroke in a Chinese hospital.

Chin Med J (Engl). 2009 Nov 5;122(21):2567-72.

The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. doi: 10.1016/j.numecd.2007.04.003. Epub 2007 Oct 24.

Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.

Clin Drug Investig. 2003;23(10):639-50. doi: 10.2165/00044011-200323100-00003.

The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients.

Diabetes Obes Metab. 2006 Jan;8(1):8-14. doi: 10.1111/j.1463-1326.2005.00469.x.

引用本文的文献

Pioglitazone for type 2 diabetes mellitus.

Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006060. doi: 10.1002/14651858.CD006060.pub2.

本文引用的文献

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Clin Ther. 2004 May;26(5):744-54. doi: 10.1016/s0149-2918(04)90074-4.

Lipids and lipoproteins in patients with type 2 diabetes.

Diabetes Care. 2004 Jun;27(6):1496-504. doi: 10.2337/diacare.27.6.1496.

The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.

Diabetes Obes Metab. 2004 Mar;6(2):133-56. doi: 10.1111/j.1462-8902.2004.00325.x.

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

Diabetes Care. 2004 Jan;27(1):141-7. doi: 10.2337/diacare.27.1.141.

Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.

Diabetes Care. 2003 Sep;26(9):2588-94. doi: 10.2337/diacare.26.9.2588.

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.

Drugs. 2003;63(13):1373-405. doi: 10.2165/00003495-200363130-00004.

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

Clin Ther. 2003 Apr;25(4):1074-95. doi: 10.1016/s0149-2918(03)80068-1.

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus.

Am J Cardiol. 2002 Nov 1;90(9):947-52. doi: 10.1016/s0002-9149(02)02659-0.

Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.

Diabetes Technol Ther. 2002;4(2):145-51. doi: 10.1089/15209150260007354.

Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.

Int J Clin Pract. 2002 May;56(4):251-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验